Montelukast Prescribing at HARVEY GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
496
Total Quantity
20.2K
NHS Cost
£1.0K
vs National Avg
-27.6%
HARVEY GROUP PRACTICE prescribed 496 items of Montelukast over the last 12 months at a cost of £1,003 to the NHS. This is 27.6% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
47
Jun 2026
39
Jun 2026
40
Jun 2026
43
Jun 2026
42
Jun 2026
45
Jun 2026
43
Jun 2026
47
Jun 2026
56
Jun 2026
23
Jun 2026
35
Jun 2026
36
Prescribing Details
| Total Items | 496 |
|---|---|
| Total Quantity | 20,205 |
| Total NHS Cost | £1,003 |
| Presentations | 4 different forms |
| vs National Average | -27.6% |
Montelukast Prescribing Comparison
| This practice | 496 items |
|---|---|
| National average per practice | 685 items |
| Difference | -27.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.